Certara, Inc. (CERT) vs Omnicell, Inc. (OMCL)
Certara, Inc. and Omnicell, Inc. are both Health Information Services companies. Omnicell, Inc. is the larger, with a market value of $1.5B against $1.4B — 1.1× the size. Certara, Inc. has negative trailing earnings, so its P/E is not meaningful; Omnicell, Inc. trades at 39.5×. Omnicell, Inc. grew revenue faster over the last twelve months: 8.45% against 6.89%. Omnicell, Inc. has the higher net margin (3.13% vs −16.3%) and the higher return on invested capital (3.10% vs 0.07%). Across the 21 metrics below, Omnicell, Inc. leads on 15 and Certara, Inc. on 6.
Valuation
Profitability
| Metric | CERT | OMCL | Health Information Services median |
|---|---|---|---|
| Gross margin | 61.48% | 44.77% | 63.38% |
| Operating margin | 0.29% | 4.65% | (8.35%) |
| Net margin | (16.26%) | 3.13% | (14.70%) |
| Free cash flow margin | 12.97% | 10.17% | 0.58% |
| Return on equity | (6.72%) | 3.06% | (6.82%) |
| Return on assets | (4.65%) | 1.89% | (6.02%) |
| Return on invested capital | 0.07% | 3.10% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack